Verrica Pharmaceuticals Inc (NASDAQ:VRCA)

Delayed Data
As of 3:59pm ET
 +0.15 / +2.32%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Verrica Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 15.00 and a low estimate of 10.00. The median estimate represents a +66.16% increase from the last price of 6.62.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Verrica Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -35.98%
Growthannually -47.27%


Growthquarterly 278.82%
Growthannually 10.73%
Key to the earnings and sales forecast charts.